Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers-Reference-Cited by-同舟云学术

Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers

Published:2016-11 Issue:11 Volume:24 Page:2278-2288
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Fujioka Ken¹,O'Neil Patrick M.²,Davies Melanie³,Greenway Frank⁴,C.W. Lau David⁵,Claudius Birgitte⁶,Skjøth Trine Vang⁶,Bjørn Jensen Christine⁶,P.H. Wilding John⁷

Affiliation:

1. Scripps ClinicLa Jolla California USA

2. Department of Psychiatry and Behavioral Sciences, Weight Management CenterMedical University of South CarolinaCharleston South Carolina USA

3. Department of Health Sciences, Diabetes Research Centre, University of LeicesterLeicester UK

4. Pennington Biomedical Research CenterBaton Rouge Louisiana USA

5. Departments of Medicine, Biochemistry and Molecular Biology, University of Calgary Cumming School of MedicineCalgary Alberta Canada

6. Novo Nordisk A/SSøborg Denmark

7. Department of Obesity and Endocrinology, University of LiverpoolLiverpool UK.

Funder

Novo Nordisk A/S

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.21629

Reference30 articles.

1. Golden J.FDA 2007 Draft Guidance for Industry: Developing Products for Weight Management. Endocrinologic and Metabolic Drugs Advisory Committee Meeting. March 28 2012.http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM299133.pdf. Accessed 5 May2016.

2. European Medicines Agency.Guideline on Clinical Evaluation of Medicinal Products used in Weight Control.http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/07/WC500170278.pdf. Published 2014 June 26. Accessed 5 May2016.

3. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline

4. Clinical correlates of short‐ and long‐term weight loss;Wadden TA;Am J Clin Nutr,1992

5. Early treatment response as a predictor of ongoing weight loss in obesity treatment

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weight Loss Pharmacotherapy;Gastrointestinal Endoscopy Clinics of North America;2024-10

2. Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy;International Journal of Obesity;2024-08-10

3. Treatment with liraglutide or naltrexone-bupropion in patients with genetic obesity: a real-world study;eClinicalMedicine;2024-08

4. Super response to liraglutide in people with obesity: A case report and literature review;Endocrinología, Diabetes y Nutrición;2024-08

5. Correlation between type 2 diabetes mellitus remission and intrapancreatic fat deposition;World Journal of Clinical Cases;2024-07-26